Lipid-altering efficacy of ezetimibe plus statin and statin monotherapy and identification of factors associated with treatment response: A pooled analysis of over 21,000 subjects from 27 clinical trials
Doralisa Morrone(Christiana Care Health System), William S. Weintraub(Christiana Care Health System), Peter P. Tóth(CGH Medical Center), Mary E. Hanson(Merck & Co., Inc., Rahway, NJ, USA (United States)), Robert S. Lowe(Merck & Co., Inc., Rahway, NJ, USA (United States)), Jianxin Lin(Merck & Co., Inc., Rahway, NJ, USA (United States)), Arvind Shah(Merck & Co., Inc., Rahway, NJ, USA (United States)), Andrew M. Tershakovec(Merck & Co., Inc., Rahway, NJ, USA (United States))
Cited by 262
Abstract
Related Papers
No related papers found
Powered by citation graph analysis